O13 Innate immunity transcriptional profiles as potential predictive biomarkers for treatment response in systemic lupus erythematosus: Insights from a longitudinal study

Similar Items

• Restoration of aberrant gene expression of monocytes in systemic lupus erythematosus via a combined transcriptome-reversal and network-based drug repurposing strategy
  by: Dimitrios Nikolakis, et al.
  Published: (2023-04-01)
• Clinical response trajectories and drug persistence in systemic lupus erythematosus patients on belimumab treatment: A real-life, multicentre observational study
  by: Myrto Nikoloudaki, et al.
  Published: (2023-01-01)
• P88 Baseline factors associated with subsequent development of incident nephritis in patients with systemic lupus erythematosus: a retrospective cohort study
  by: Dimitrios T Boumpas, et al.
  Published: (2024-03-01)
• P100 Efficacy of anifrolumab in multi-refractory skin manifestations of systemic lupus erythematosus: case series
  by: George Bertsias, et al.
  Published: (2024-03-01)
• The genomic landscape of ANCA-associated vasculitis: Distinct transcriptional signatures, molecular endotypes and comparison with systemic lupus erythematosus
  by: Aggelos Banos, et al.
  Published: (2023-03-01)